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The use of cessation assistance among smokers
from China: Findings from the ITC China Survey
Jilan Yang1, David Hammond1*, Pete Driezen1, Richard J O’Connor2, Qiang Li3, Hua-Hie Yong4, Geoffrey T Fong5,6,
Yuan Jiang3
Abstract
Background: Stop smoking medications significantly increase the likelihood of smoking cessation. However, there
are no population-based studies of stop-smoking medication use in China, the largest tobacco market in the world.
This study examined stop-smoking medication use and its association with quitting behavior among a population-
based sample of Chinese smokers.
Methods: Face-to-face interviews were conducted with 4,627 smokers from six cities in the ITC China cohort
survey. Longitudinal analyses were conducted using Wave 1 (April to August, 2006) and Wave 2 (November 2007
to January 2008).
Results: Approximately 26% of smokers had attempted to quit between Waves 1 and 2, and 6% were abstinent at
18-month follow-up. Only 5.8% of those attempting to quit reported NRT use and NRT was associated with lower
odds of abstinence at Wave 2 (OR = 0.11; 95%CI = 0.03-0.46). Visiting a doctor/health professional was associated
with greater attempts to quit smoking (OR = 1.60 and 2.78; 95%CI = 1.22-2.10 and 2.21-3.49 respectively) and
being abstinent (OR = 1.77 and 1.85; 95%CI = 1.18-2.66 and 1.13-3.04 respectively) at 18-month follow-up relative
to the smokers who did not visit doctor/health professional.
Conclusions: The use of formal help for smoking cessation is low in China. There is an urgent need to explore the
use and effectiveness of stop-smoking medications in China and in other non-Western markets.
Background
Cigarette smoking is the single largest preventable cause
of premature death worldwide. Up to one half of long-
term smokers will die from smoking-related disease
[1-3]. Smoking kills more than 5 million people each
year and the death toll will double by 2030 if current
trends continue [4].
Quitting smoking reduces the risk of smoking-attribu-
table disease. People who quit smoking, regardless of
their age, are less likely to die from smoking compared
with those who continue to smoke. Smokers who quit
before the onset of major smoking-attributable disease
avoid most of the excess negative health effects of smok-
ing [5]. For example, smokers who stop smoking before
middle age avoid more than 90% of the lung cancer risk
caused by smoking [3]. Recent research indicates that
quitting smoking even after a diagnosis of lung cancer
substantially increases survivorship rates [6]. Therefore,
interventions that promote smoking cessation are
among the most important public health measures
available.
Although more than 80% of the world’s smokers live
in low and middle income countries, smoking cessation
rates in these countries are significantly lower than in
high income countries [7]. In high income countries
such as the United States, Canada and the Netherlands,
former smokers comprise about 30% of the population,
in contrast to developing countries such as China,
where former smokers account for less than 10% of the
population [7].
As the most populous country in the world, China is
home to 350 million, or one third of the world’s smo-
kers. Although estimates of cessation rates in China vary
across studies, they are consistently low. A national
study conducted in 1996 concluded that less than 1% of
“established” smokers (individuals who had smoked for
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at least 6 months) had quit for more than two years [8].
A more recent national study conducted in 2003
reported that the “quit rate”, defined as smokers who
had quit for more than two years among those who had
smoked over 100 cigarettes, was 2.5% [9]. Several local
studies report higher quit rates -9% in Shanghai [10], 6%
in Chengdu [11] and 11% in Jiangsu province [12] –
however, these numbers are consistently lower than
rates in Western countries.
Research in Western countries has found that smokers
who receive formal cessation assistance are more likely to
be successful in quitting [13]. Nicotine Replacement Ther-
apy (NRT), such as nicotine gum, the patch and the nico-
tine lozenge, increases the odds of quitting compared with
placebo between 1.5 to 2 fold in clinical trials [14] and in
over-the-counter (OTC) NRT use [15]. Self-help materials,
telephone quitlines, and brief advice from health profes-
sional, and more intensive behavioural counselling have
also been shown to increase odds of quitting [13].
In China, the types and effectiveness of smoking ces-
sation assistance used by smokers remain largely unex-
plored. Several clinical studies in China have shown that
both NRT and professional counselling are effective
among adult smokers [16-18], elder smokers who were
over 60 years old [19], and young smokers who were
under 24 years old [20]. However, the use of cessation
assistance in China appears to be low [21]. A recent
local study conducted in Huangshi, Hubei province indi-
cated that 98% of smokers who had attempted to quit
did so on their own, without formal assistance [22].
Overall, there is little population-based data on stop
smoking medication use among Chinese smokers.
The purpose of the current study is to explore health
advice from doctors/health professionals, the use of stop
smoking methods and smoking abstinence among a
population-based sample of Chinese smokers.
Methods
Sample
The International Tobacco Control (ITC) China project
is a prospective cohort survey designed to evaluate
national level tobacco control policies [23]. The ITC
China cohort was recruited using a multistage cluster
sampling method to obtain a representative sample of
adult smokers who were registered residents in the six
cities. In each of the six cities, 10 Jie Dao or Street Dis-
tricts were selected with probability of selection propor-
tional to population size of the Jie Dao. Within each of
these Jie Dao, two Ju Wei Hui or residential blocks were
selected, again with probability of selection proportional
to size. Within each Ju Wei Hui, the addresses of the
dwelling units (households) were listed first, and then a
sample of 300 addresses were drawn by simple random
sampling without replacement. Information on age,
gender and smoking status for all adults living in these
300 households is collected. The enumerated 300 house-
holds were then randomly ordered, adult smokers were
then approached following the randomized order until
40 adult smokers were surveyed. Wave 1(April to
August, 2006) of the ITC China survey was conducted
in 4,732, and Wave 2(November 2007 to January 2008)
was conducted in 4,566. [24]. A total of 3,868 smokers
from Wave 1 were successful re-contacted in Wave 2
(83% retention), among which 3,651 were smokers and
217 were abstinent at follow up. Due to missing data, a
total 3,824 respondents were included in the analysis, of
which 3,616 were smokers and 208 were quitters who
reported abstinent at Wave 2.
The ITC China Survey was conducted through face-
to-face interviews. All interviewers followed a standard
protocol in their interview session with each respondent.
Up to four visits to a household were made in order to
interview the target person(s) within that household.
The enumerators and survey interviewers were trained
by the China CDC staff in each city, with support and
supervision from the ITC China team.
All training materials and forms for the enumeration
process and the survey interviewing were developed
together. Several quality control procedures were put in
place, including MP3 audio recording smokers’ survey
by interviewers and checking by quality controller in
each city.
All materials and procedures used in the ITC China
Survey were reviewed and cleared for ethics by the
Research Ethics Board at the University of Waterloo and
by the Institutional Review Boards at the China National
Centers for Disease Control and Prevention.
Measures
Demographics
Age was categorized as “18-24; 25-39; 40-54; 55+”. Edu-
cation level was categorized into “low” (no education &
elementary school); “middle” (Junior high school & high
school); and “high” levels (college and higher)”. House-
hold monthly income was classified as “low” (3000 yuan
and under), “middle” (3001-5000 yuan), and “high”
(5001 and above).
Smoking status and quitting behaviour
All respondents were smokers (100 cigarettes in lifetime
and were smoking at time of Wave 1 survey). Smoking
status at Wave 2 was measured by asking “Do you cur-
rently smoke or have you quit?” The respondents who
self-reported that they had quit were categorized as
quitters. Length of smoking abstinence among quitters
was measured. Quit attempt was measured by the ques-
tion of “Since we last talked to you in 2006, how many
times have you tried to quit smoking?” Among smokers,
the number of quit attempts, date of last quit attempt,
Yang et al. BMC Public Health 2011, 11:75
http://www.biomedcentral.com/1471-2458/11/75
Page 2 of 8
and length of abstinence of last quit attempt since the
Wave 1 survey were assessed.
Smoking cessation assistance
All respondents were asked if they had used stop smok-
ing medications, such as nicotine patch, nicotine gum,
Zyban, traditional Chinese medicine and acupuncture
since the last survey date.
Quit advice from doctors/health professionals
All respondents were asked if they visited a doctor/
health professional since the last survey. Respondents
who reported visiting a doctor/health professional were
asked if they received any advice during their visit.
Respondents were categorized into three groups: (1) no
visit to doctor/health professional since last survey,
(2) visited doctor/health professional but did not receive
advice to quit smoking, and (3) visited doctor/health
professional and received advice to quit smoking.
Analysis
All statistical analyses were performed using SAS version
9.2 (SAS Institute Inc., Cary, NC). Analyses were weighted
to ensure results were representative of smokers in the six
cities included in the ITC China project [23]. Analyses
also accounted for the multi-stage sampling design. Unless
otherwise noted, all estimates, including percentages, odds
ratios (OR) and 95% confidence intervals (95% CI), are
weighted estimates while samples sizes are unweighted.
Logistic regression was used to test differences in quitting
behaviour, use of cessation methods, and visiting a doctor/
health professionals and receiving advice to quit during
those visits. All odds ratios presented controlled for Wave
1 measures of gender, age, income, education, and daily
cigarette consumption.
Results
Sample characteristics
As shown in Table 1, more than 95% of respondents
were male, consistent with prevalence rates in China.
The majority of respondents (83.1%) smoked less
20 cigarettes per day.
Quitting behaviour
Figure 1 shows patterns of cessation behaviour between
Waves 1 and 2. Among the respondents who self-reported
abstinence at Wave 2, less than half of them reported
being abstinent for less than 6 months (Figure 1).
Quit Attempts
A logistic regression was conducted to examine socio-
demographic predictors of quit attempts made between
Wave 1 and Wave 2 (Table 2). Smokers age 55 and older
had slightly greater odds of making a quit attempt com-
pared to 18-39 year olds (OR = 1.25, 95%CI = 0.95-1.66).
High and middle income smokers had significantly lower
odds of making quit attempts relative to low income
smokers (OR = 0.72 and 0.66, respectively). Compared
with smokers who consumed less than 10 cigarettes per
day, smokers who had 11-20 cigarette, 21-30 cigarette or
more than 31 cigarettes per day had significantly lower
odds of making a quit attempt (OR = 0.71, 0.54 and 0.58,
respectively).
Smoking abstinence
Table 2 also shows the results of a logistic regression
predicting abstinence at Wave 2. Smokers who were 55
or older had greater odds of being abstinent at Wave 2
(OR = 3.16) relative to 18-39 year olds. High income
smokers had 2.11 times greater odds of being abstinent
than low income smokers. Smokers in high education
group were less likely to be smoking abstinent compared
with low education group (OR = 0.45). Compared with
smokers who consumed less than 10 cigarettes per day,
those smokers who had 11-20 cigarette; 21-30 cigarette;
over 31 cigarette per day had significant lower odds of
being abstinent (OR = 0.53, 0.37, 0.39, respectively).
Visiting doctors/health professionals and quitting advice
A total of 33.6% (n = 1,269) of smokers visited doctors/
health professionals in the 18 months since Wave 1.
Table 1 Sample characteristics at Wave 2 of the ITC
China Survey (N = 3,824)
Smokers “Quitters” Total
% n % n % n
Sex
Male 95.2 3442 92.8 193 95.1 3635
Female 4.8 174 7.2 15 4.9 189
Age
18-39 16.8 607 10.1 21 16.4 628
40-54 49.8 1801 37.5 78 49.1 1879
55+ 33.4 1208 52.4 109 34.4 1317
Income
Low 15.6 564 14.9 31 15.6 595
Middle 46.5 1681 48.1 100 46.6 1781
High 31.9 1154 32.7 68 32.0 1222
No answer 6.0 217 4.3 9 5.9 226
Education
Low 11.5 416 22.1 46 12.1 462
Middle 67.6 2446 59.1 123 67.2 2569
High 20.9 754 18.8 39 20.7 793
Cigarettes smoked/day
0-10 33.2 1200 51.0 106 34.2 1306
11-20 49.9 1804 38.0 79 49.2 1883
21-30 9.2 331 5.3 11 8.9 342
31+ 7.7 281 5.8 12 7.7 293
Yang et al. BMC Public Health 2011, 11:75
http://www.biomedcentral.com/1471-2458/11/75
Page 3 of 8
Among those who visited doctors/health professionals,
17.4% of total sample (n = 663) received quitting advice
during their visit and 10.9% (n = 418) of those who
received advice reported that the advice was helpful.
Logistic regression models estimated the likelihood of
visiting a doctor/health professional and receiving advice,
attempting to quit, and being abstinent, adjusting for age,
gender, income, education and cigarette consumption
per day. As Table 3 shows, the odds of visiting a doctor
(OR = 1.56, 95%CI = 1.06 - 2.29) and visiting a doctor
and receiving advice was greater among smokers aged 55
and older (OR = 2.58, 95%CI = 1.49 - 4.47). High and
middle income smokers were also more likely to have vis-
ited a doctor (OR = 1.44, 95%CI = 1.05 - 1.97; OR = 1.84,
95%CI = 1.21 - 2.81, respectively), while high income
smokers had greater odds than low income smokers of
receiving quit advice during a doctor/health professional
visit (OR = 1.60; 95%CI = 1.06-2.41).
Smokers who had visited a doctor/health professional
and received advice since baseline had significant greater
odds of making a quit attempt (OR = 2.78; 95%CI = 2.21-
3.49) and being abstinent (OR = 1.85, 95%CI = 1.13-3.04)
at Wave 2, compared to smokers who did not visit a doc-
tors/health professional since Wave 1. Even smokers who
visited a doctor/health professional but did not receive
advice, had significantly greater odds of making a quit
attempt (OR = 1.60; 95%CI = 1.22-2.10) and being absti-
nence (OR = 1.77, 95%CI = 1.18-2.66), relative to the
smokers who did not visit a doctor/health professional.
Among smokers who visited a doctor/health professional,
those who had received quitting advice during the visit
were significantly more likely to have made a quitting
attempt (OR = 1.74, 95%CI = 1.31-2.30), but not signifi-
cantly more likely to be abstinent at follow-up (OR =
1.04, 95%CI = 0.59-1.86; data not shown in table).
Use of stop smoking medications
Of the smokers who attempted to quit between Waves 1
and 2 (n = 967), 5.8% (n = 62) reported using NRT and/or
Zyban. A total of 2.1% (n = 25) reported using “traditional
Chinese medicine” and less than one percent (n = 10)
reported using acupuncture as a smoking cessation aid.
Among all the smokers who attempted to quit between
two waves, approximately 1.4% (n = 17) reported using
more than one stop smoking medications.
Predictors of stop-smoking medication use
Logistic regression models were conducted to examine
demographic predictors of NRT and/or Zyban use, and
“traditional Chinese medicine” and/or acupuncture use.
No significant association was observed for NRT/Zyban
use across age, gender, income, education, and cigarettes
per day, and the number of prior quit attempts. How-
ever, smokers with higher education were 4.28 times
more likely to use traditional Chinese medicine/acu-
puncture (95%CI = 1.41-12.97) than smokers in middle
education level.
Stop-smoking medications and abstinence
Among those who attempted to quit and exclusively
used NRT and/or Zyban as stop smoking assistance
(n = 50), only 3.3% (n = 2) reported being abstinent at
Abstinent < 1m 
61.3% (n=457)         
Abstinent < 1m 
4.2% (n=8) 
All respondents 
100% (N=3824)  
No Attempts to 
Quit  
74.1% (n=2857) 
At least one quit 
attempt 
25.9% (n=967)  
Relapse 
76.4% (n=759)  
Abstinent at 
Wave2 23.6% 
(n=208) 
Abstinent 1-6m 
35.0% (n=263)          
Abstinent 7-12 m 
3.6% (n=29)                 
Abstinent 7-12m 
44.7% (n=96)            
Abstinent 1-6 m 
45.1% (n=88)            
Abstinent > 12 m 
6.0% (n=16)              
Figure 1 Quitting behaviour between Wave 1 and 2 (N = 3,824). *All estimates presented in Figure 1 are weighted results accounting for
multi-stage sampling design.
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Wave 2. In contrast, among smokers who tried to quit
smoking on their own (n = 885), 24.8% (n = 200) were
smoking abstinent at Wave 2. As Table 4 shows, smo-
kers who used NRT were significantly less likely to be
abstinent at Wave 2 compared with those attempting to
quit without assistance after adjusting for age, gender,
education, income, and cigarette consumption per day
and prior quit attempts (OR = 0.11, 95%CI = 0.03-0.46).
Among those who quit using traditional Chinese medi-
cine (n = 13) exclusively, 16.4% (n = 2) reported absti-
nence at follow-up. There was no significant difference
in abstinence between quitters who reported using tradi-
tional Chinese medicine and acupuncture, and those
who reported no cessation assistance (see Table 4).
Discussion
Given the looming health burden from 350 million
tobacco users in China, efforts to increase smoking ces-
sation rates are among the most important public health
measures in China. The current study indicates that the
prevalence of smokers actively trying to quit smoking in
China is significantly lower than in Western countries.
Approximately one quarter of Chinese smokers reported
trying to quit in the last 18 months compared to almost
half of smokers in the US and Canada [13,25]. These
findings are consistent with reports of lower motivation
to quit among Chinese smokers [26], which may reflect
lower levels of health knowledge or more supportive
social norms towards smoking in China [27].
According to available research, about half of quitters
who are abstinent for less than 6 month will subse-
quently relapse, and one-fifth of those abstinent for six
to twelve month will relapse [28], Therefore, the propor-
tion of smokers in the current study who will achieve
long term abstinence is likely to be well below the 6% of
smokers who reported abstinence at follow-up. Current
estimates indicate that annual quit rate in low and mid-
dle income countries is typically 4% to 7% [13,15].
Therefore, the actual quit rate in China is likely lower
than that in high income countries.
Low income smokers in the current study were more
likely to make quit attempts than smokers with higher
income; however, lower income smokers were less likely
to report smoking abstinence. In other words, lower
income smokers may be have greater interest in quitting
but have lower capacity to maintain abstinence. This
finding suggests that there is a need in China for popu-
lation-based smoking cessation interventions to ensure
that smokers from low socioeconomic groups have
greater access to effective forms of cessation assistance.
Visiting doctors/health professionals was associated
with greater attempts to quit smoking and abstinence.
However, receiving advice on quitting during the doc-
tor/health professional visit was not associated with
higher levels of abstinence among those attempting to
quit. Several factors may account for this finding. First,
research suggests that smoking prevalence is as high as
23% among Chinese physicians and 41% among male
physicians. Knowledge of the health effects of smoking
also appears to be low among physicians: in 2007, only
two thirds of Chinese physicians reported that smoking
causes heart disease [29]. This lack of knowledge may
limit the capacity of health professionals to effectively
advise smokers. Second, approximately two thirds of
Chinese physicians do not believe that smokers would
follow their cessation advice [29]. Despite this, a major-
ity of smokers who visited a doctor/health professional
in the current study received cessation advice. This find-
ing highlights the need to examine the content of health
professionals’ advice to a greater extent.
Use of stop smoking medications among Chinese
smokers was extremely low–less than 6% for NRT and
Zyban combined. Given that the current sample is
drawn from large urban centers in China, NRT use is
likely to be even lower among smokers in rural areas
and entire population in China. The current findings are
Table 2 Adjusted odds ratios of demographic predictors
of quit attempts and abstinence at 18-month follow up
Covariate Quit attempts Abstinence at Wave 2
(N = 3,824) (N = 3,824)
OR 95% CI OR 95% CI
Sex
Male 1.00 1.00
Female 0.96 0.66 - 1.41 1.01 0.49 - 2.08
Age
18-39 1.00 1.00
40-54 0.92 0.72 - 1.17 1.75 0.92 - 3.33
55+ 1.25 0.95 - 1.66 3.16 1.76 - 5.68
Income
Low 1.00 1.00
Middle 0.66 0.51 - 0.86 1.27 0.69 - 2.34
High 0.72 0.52 - 1.00 2.11 1.01 - 4.38
No answer 0.44 0.24 - 0.81 0.70 0.31 - 1.60
Education
Low 1.00 1.00
Middle 1.12 0.84 - 1.49 0.63 0.36 - 1.12
High 1.10 0.77 - 1.56 0.45 0.25 - 0.83
Cigarettes smoked/day
0-10 1.00 1.00
11-20 0.71 0.60 - 0.84 0.53 0.37 - 0.77
21-30 0.54 0.40 - 0.72 0.37 0.17 - 0.81
31+ 0.58 0.40 - 0.83 0.39 0.17 - 0.89
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consistent with recent evidence indicating that few smo-
kers regard NRT as an effective and viable smoking ces-
sation aid given the high price and relatively low levels
of marketing in China [30].
Evidence from developed countries supports the effec-
tiveness of stop-smoking medications such as NRT and
Zyban, which are among the “first-line” treatments for
smoking cessation in Western countries [13,14]. How-
ever, the results from the current study suggest that Chi-
nese smokers who quit using NRT were significantly less
likely to be abstinent at follow-up, compared with those
who quit without stop-smoking medications. Although
several clinical trials support the effectiveness of NRT
among Chinese smokers [16-18], our findings are the
first “real-world” evaluation of NRT among Chinese smo-
kers to our knowledge. These preliminary findings
suggest no positive impact from NRT among Chinese
smokers after previous quit attempts were controlled
after adjusting for important factors such as prior quit
attempts [31]. Nevertheless, the findings highlight the
need for additional population-based study to examine
the effectiveness of stop-smoking medications outside of
clinical trials in low and middle income countries. Even
in high income Western countries, some within the
tobacco control community have questioned the popula-
tion-level benefit of stop-smoking medications [32]. The
question of whether low and middle income countries
such as China should invest heavily in smoking cessation
services and aggressively promote greater use of pharma-
cotherapy is also being addressed as part of the World
Health Organization’s Framework Convention on
Tobacco Control (FCTC), the world’s first public health
Table 3 Association of visiting the doctors/health professionals and receiving advice to quit smoking, quit attempts,
and abstinence among all smokers (n = 3,810)
Doctor’s Visit & Advice to Quit* Quit attempts Abstinence at Wave 2
Visited doctor, no advice Visited & advised to quit
Covariate OR 95% CI P OR 95% CI P OR 95% CI P OR 95% CI P
Sex
Male 1.00 1.00 1.00 1.00
Female 1.29 0.81 - 2.06 0.28 0.96 0.64-1.46 0.87 0.97 0.67 - 1.42 0.89 0.99 0.48 - 2.05 0.99
Age
18-39 1.00 1.00 1.00 1.00
40-54 1.02 0.75 - 1.37 0.91 1.31 0.81 - 2.14 0.28 0.91 0.71 - 1.17 0.47 1.71 0.90 - 3.26 0.10
55+ 1.56 1.06 - 2.29 0.02 2.58 1.49 - 4.47 <0.001 1.11 0.85 - 1.46 0.446 2.86 1.58 - 5.17 <0.001
Income
Low 1.00 1.00 1.00 1.00
Middle 1.44 1.05 - 1.97 0.03 1.20 0.83 - 1.74 0.33 0.62 0.48 - 0.80 <0.001 1.23 0.67 - 2.27 0.51
High 1.84 1.21 - 2.81 0.01 1.60 1.06 - 2.41 0.03 0.65 0.47 - 0.91 0.01 1.98 0.95 - 4.12 0.07
No answer 2.20 1.29 - 3.74 0.004 1.59 0.81 - 3.12 0.18 0.38 0.21 - 0.69 0.001 0.65 0.28 - 1.49 0.31
Education
Low 1.00 1.00 1.00 1.00
Middle 0.69 0.46 - 1.04 0.07 0.87 0.63 - 1.20 0.40 1.20 0.89 - 1.64 0.23 0.66 0.37 - 1.16 0.15
High 0.91 0.61 - 1.36 0.64 0.82 0.54 - 1.23 0.34 1.17 0.79 - 1.72 0.44 0.45 0.24 - 0.85 0.01
Cigarettes smoked/day
0 - 10 1.00 1.00 1.00 1.00
11 - 20 0.68 0.52 - 0.89 0.01 0.74 0.55 - 0.99 0.04 0.74 0.62 - 0.89 0.001 0.56 0.38 - 0.81 0.002
21 - 30 0.66 0.43 - 1.01 0.06 0.99 0.68 - 1.46 0.97 0.52 0.39 - 0.70 <0.001 0.37 0.17 - 0.81 0.01
31+ 0.55 0.32 - 0.95 0.03 0.67 0.47 - 0.96 0.03 0.58 0.41 - 0.81 0.001 0.42 0.19 - 0.96 0.04
Doctor’s advice to quit
Did not visit doctor N/A 1.00 1.00
Visited doctor, no advice 1.60 1.22 - 2.10 <0.001 1.77 1.18 - 2.66 0.01
Visited & advised to quit 2.78 2.21 - 3.49 <0.001 1.85 1.13 - 3.04 0.02
*Based on a multinomial logit model using doctor/health professional visit and advice to quit as the outcome variable, where “Did not visit doctors/health
professionals since last survey” was used as the reference category.
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treaty. Article 14 of the FCTC treaty requires countries to
promote the use of smoking cessation services; however,
the extent to which low and middle income countries
should following the model of countries such as the Uni-
ted Kingdom and South Korea and invest in cessation
clinics and subsidies for medications is a pressing issue
for which little evidence exists to guide regulations.
Limitations
This study has several limitations common to survey
research, including the limitations of self-reported data
and potential sample bias. In particular, abstinence was
self-reported at follow-up and not biochemically veri-
fied in any way. A measure of continuous abstinence,
such as sustained 6-month abstinence, would yield
lower estimates of cessation activity. However, the
response rates of the ITC China are significantly
higher than those commonly reported in Western
countries and the cohort design of this study is a con-
siderable strength.
Conclusions
Tobacco control activities in China have lagged behind
most Western countries. China has recently taken sev-
eral important recent steps, including ratifying the
WHO FCTC, implementing smoke-free policies, as well
as launching several media campaigns. However, the
current study indicates that rates of smoking cessation
in China are considerably lower than in Western coun-
tries. Very few Chinese smokers use formal assistance
when trying to quit, including stop-smoking medica-
tions. In addition, preliminary findings suggest that smo-
kers who used NRT or Zyban were less likely to quit
than Chinese smokers who reported quitting without
assistance. The findings highlight the urgent need to
better understand patterns of quitting and the use of
cessation assistance in China, as well as other low and
middle income countries which bear the overwhelming
global burden of disease from tobacco use.
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Table 4 Association between stop-smoking medications
and abstinence among respondents that made at least
one quit attempt (n = 955)
Covariates OR 95% CI P level
Sex
Male 1.00 -
Female 1.39 0.54 - 3.56 0.50
Age
18-39 1.00 -
40-54 2.06 1.14 - 3.72 0.02
55+ 3.07 1.63 - 5.78 <0.001
Income
Low 1.00 -
Middle 1.97 0.95 - 4.11 0.07
High 3.62 1.68 - 7.78 0.001
No answer 1.18 0.40 - 3.49 0.77
Education
Low 1.00 -
Middle 0.50 0.26 - 0.97 0.04
High 0.29 0.14 - 0.62 0.001
Cigarettes smoked/day
0-10 1.00 -
11-20 0.64 0.40 - 1.02 0.06
21-30 0.51 0.19 - 1.42 0.20
31+ 0.63 0.26 - 1.55 0.32
Prior Attempts
None 1.00 -
Once 0.99 0.61 - 1.62 0.98
2-5 times 0.87 0.25 - 3.12 0.84
6-10 times 1.17 0.42 - 3.23 0.76
Cessation assistance
No assistance 1.00 -
NRT or Zyban 0.11 0.03 - 0.46 0.002
Used traditional Chinese
medicine or acupuncture
0.61 0.15 - 2.43 0.48
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